159 related articles for article (PubMed ID: 33420502)
21. [Consultation in breast surgical pathology: interobserver diagnostic variability of atypical intraductal proliferative lesions].
Perez AA; Balabram D; Salles Mde A; Gobbi H
Rev Bras Ginecol Obstet; 2013 Apr; 35(4):164-70. PubMed ID: 23752581
[TBL] [Abstract][Full Text] [Related]
22. Ipsilateral local recurrence in relation to therapy and morphological characteristics in patients with ductal carcinoma in situ of the breast.
Ringberg A; Idvall I; Fernö M; Anderson H; Anagnostaki L; Boiesen P; Bondesson L; Holm E; Johansson S; Lindholm K; Ljungberg O; Ostberg G
Eur J Surg Oncol; 2000 Aug; 26(5):444-51. PubMed ID: 11016463
[TBL] [Abstract][Full Text] [Related]
23. Cytochrome c1 in ductal carcinoma in situ of breast associated with proliferation and comedo necrosis.
Chishiki M; Takagi K; Sato A; Miki Y; Yamamoto Y; Ebata A; Shibahara Y; Watanabe M; Ishida T; Sasano H; Suzuki T
Cancer Sci; 2017 Jul; 108(7):1510-1519. PubMed ID: 28394473
[TBL] [Abstract][Full Text] [Related]
24. Thirty percent of ductal carcinoma in situ of the breast in Japan is extremely low-grade ER(+)/HER2(-) type without comedo necrosis.
Kanematsu M; Morimoto M; Takahashi M; Honda J; Bando Y; Moriya T; Tadokoro Y; Nakagawa M; Takechi H; Yoshida T; Toba H; Yoshida M; Kajikawa A; Tangoku A; Imoto I; Sasa M
J Med Invest; 2016; 63(3-4):192-8. PubMed ID: 27644557
[TBL] [Abstract][Full Text] [Related]
25. Correlation of nuclear morphometry with pathologic parameters in ductal carcinoma in situ of the breast.
Tan PH; Goh BB; Chiang G; Bay BH
Mod Pathol; 2001 Oct; 14(10):937-41. PubMed ID: 11598161
[TBL] [Abstract][Full Text] [Related]
26. Comparative features of comedo and noncomedo ductal carcinoma in situ of the breast on fine-needle aspiration biopsy.
Malamud YR; Ducatman BS; Wang HH
Diagn Cytopathol; 1992; 8(6):571-6. PubMed ID: 1334826
[TBL] [Abstract][Full Text] [Related]
27. Histopathological grading of breast ductal carcinoma in situ: validation of a web-based survey through intra-observer reproducibility analysis.
Schuh F; Biazús JV; Resetkova E; Benfica CZ; Ventura Ade F; Uchoa D; Graudenz M; Edelweiss MI
Diagn Pathol; 2015 Jul; 10():93. PubMed ID: 26159429
[TBL] [Abstract][Full Text] [Related]
28. A quantitative model using mean and standard deviation for evaluation of interobserver agreement in nuclear atypia scoring of breast carcinomas in a protocol study.
Tsuda H; Akiyama F; Kurosumi M; Sakamoto G; Watanabe T
Pathol Int; 2000 Feb; 50(2):119-25. PubMed ID: 10792770
[TBL] [Abstract][Full Text] [Related]
29. Noninvasive ductal carcinoma of the breast: the relevance of histologic categorization.
Bellamy CO; McDonald C; Salter DM; Chetty U; Anderson TJ
Hum Pathol; 1993 Jan; 24(1):16-23. PubMed ID: 8380275
[TBL] [Abstract][Full Text] [Related]
30. DNA analysis of ductal carcinoma in situ of the breast. A comparison with histologic features.
Killeen JL; Namiki H
Cancer; 1991 Dec; 68(12):2602-7. PubMed ID: 1657363
[TBL] [Abstract][Full Text] [Related]
31. Ductal carcinoma in situ (intraductal carcinoma) of the breast treated with breast-conserving surgery and definitive irradiation. Correlation of pathologic parameters with outcome of treatment.
Solin LJ; Yeh IT; Kurtz J; Fourquet A; Recht A; Kuske R; McCormick B; Cross MA; Schultz DJ; Amalric R
Cancer; 1993 Apr; 71(8):2532-42. PubMed ID: 8384070
[TBL] [Abstract][Full Text] [Related]
32. Ductal carcinoma in situ of the breast: correlation between mammographic calcification and tumor subtype.
Stomper PC; Connolly JL
AJR Am J Roentgenol; 1992 Sep; 159(3):483-5. PubMed ID: 1323923
[TBL] [Abstract][Full Text] [Related]
33. Microinvasive ductal carcinoma (T1mic) of the breast. The clinicopathological profile and immunohistochemical features of 28 cases.
Yang M; Moriya T; Oguma M; De La Cruz C; Endoh M; Ishida T; Hirakawa H; Orita Y; Ohuchi N; Sasano H
Pathol Int; 2003 Jul; 53(7):422-8. PubMed ID: 12828606
[TBL] [Abstract][Full Text] [Related]
34. Diagnosis of Papillary Breast Lesions on Core Needle Biopsy: Upgrade Rates and Interobserver Variability.
Qiu L; Mais DD; Nicolas M; Nanyes J; Kist K; Nazarullah A
Int J Surg Pathol; 2019 Oct; 27(7):736-743. PubMed ID: 31187678
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of the interobserver agreement in the number of mitotic figures of breast carcinoma as simulation of quality monitoring in the Japan National Surgical Adjuvant Study of Breast Cancer (NSAS-BC) protocol.
Tsuda H; Akiyama F; Kurosumi M; Sakamoto G; Yamashiro K; Oyama T; Hasebe T; Kameyama K; Hasegawa T; Umemura S; Honma K; Ozawa T; Sasaki K; Morino H; Ohsumi S
Jpn J Cancer Res; 2000 Apr; 91(4):451-7. PubMed ID: 10804295
[TBL] [Abstract][Full Text] [Related]
36. Ductal carcinoma in situ of the breast: correlation between histopathological features and age of patients.
Perez AA; Balabram D; Salles Mde A; Gobbi H
Diagn Pathol; 2014 Dec; 9():227. PubMed ID: 25471940
[TBL] [Abstract][Full Text] [Related]
37. Evidence of significant apoptosis in poorly differentiated ductal carcinoma in situ of the breast.
Gandhi A; Holland PA; Knox WF; Potten CS; Bundred NJ
Br J Cancer; 1998 Sep; 78(6):788-94. PubMed ID: 9743302
[TBL] [Abstract][Full Text] [Related]
38. Comparison of cytomorphological and architectural heterogeneity in mammographically-detected ductal carcinoma in situ.
Harrison M; Coyne JD; Gorey T; Dervan PA
Histopathology; 1996 May; 28(5):445-50. PubMed ID: 8735720
[TBL] [Abstract][Full Text] [Related]
39. Diagnostic Reproducibility: What Happens When the Same Pathologist Interprets the Same Breast Biopsy Specimen at Two Points in Time?
Jackson SL; Frederick PD; Pepe MS; Nelson HD; Weaver DL; Allison KH; Carney PA; Geller BM; Tosteson AN; Onega T; Elmore JG
Ann Surg Oncol; 2017 May; 24(5):1234-1241. PubMed ID: 27913946
[TBL] [Abstract][Full Text] [Related]
40. Low-grade cribriform ductal carcinoma in situ of the breast. Fine needle aspiration cytology in three cases.
Lilleng R; Hagmar BM; Farrants G
Acta Cytol; 1992; 36(1):48-54. PubMed ID: 1312285
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
